E968

E968

SCHEMBL6729753

OCC(O)[C@H](O)CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
E968 SCHEMBL30287920 1.00
E968 SCHEMBL13727065 1.00 LMNA (0.67)
E968 SCHEMBL36228 1.00
E968 SCHEMBL1697009 1.00 LMNA (0.67)
E968 SCHEMBL10427336 1.00
E968 SCHEMBL121807 1.00
E968 SCHEMBL2723809 1.00 LMNA (0.67)
E968 SCHEMBL17062 1.00
E968 SCHEMBL17766 1.00
E968 SCHEMBL9566824 1.00 LMNA (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012466-A1 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-01-10 US disclosed
EP-2052250-B1 SOLID-PHASE DETECTION OF TERMINAL MONOSACCHARIDES CLEAVED FROM GLYCOSYLATED SUBSTRATES MERCK PATENT GMBH (DE) 2012-05-16 EP disclosed
US-8076466-B2 Saccharidic fluorescent substrates, their process of preparation and their use COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2011-12-13 US disclosed
EP-2351777-A1 ANTI-MUC1 ANTIBODY Shionogi & Co., Ltd. (JP) 2011-08-03 EP disclosed
US-7939230-B2 Overcoat layer comprising core-shell fluorinated particles XEROX CORPORATION (US) 2011-05-10 US disclosed
US-7928077-B2 Alpha-galactosyl ceramide analogs and their use as immunotherapies ACADEMIA SINICA (TW) 2011-04-19 US disclosed
US-20100047828-A1 SOLID-PHASE DETECTION OF TERMINAL MONOSACCHARIDES CLEAVED FROM GLYCOSYLATED SUBSTRATES MERCK PATENT GESELLSCHAFT (DE) 2010-02-25 US disclosed
US-20100008954-A1 Alpha-galactosyl ceramide analogs and their use as immunotherapies ACADEMIA SINICA (TW) 2010-01-14 US disclosed
EP-1124855-B1 COMPOSITIONS AND METHODS FOR TREATING POLYCYSTIC KIDNEY DISEASE GENZYME CORP (US) 2009-08-19 EP disclosed
US-20080171787-A1 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-07-17 US disclosed
EP-1862466-A2 Arrays with cleavable linkers The Scripps Research Institute (US) 2007-12-05 EP disclosed
WO-2007129221-A2 COMPOSITIONS COMPRISING AN EPI-INOSITOL COMPOUNDS AND METHODS FOR TREATMENT OF DISORDERS OF PROTEIN AGGREGATION WARATAH PARMACEUTICALS INC (CA) 2007-11-15 WO disclosed